News | August 13, 2021
Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
The company is confident of commencing production at both Mahad and Chiplun units soon
The company has already embarked upon significant expansion in Turkey
The company has predominantly built a portfolio into veterinary products
Revenues from operations for FY21 stood at Rs. 202.38 crore as compared to 167.27 crore, up by 21%
Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
Subscribe To Our Newsletter & Stay Updated
